Deerfield Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-32,943
Closed -$2.19M 110
2025
Q4
$2.19M Buy
32,943
+10,656
+48% +$689K 0.03% 91
2025
Q3
$1.5M Buy
+22,287
New +$1.76M 0.02% 110
2024
Q4
Sell
-7,391
Closed -$495K 211
2024
Q3
$495K Buy
+7,391
New +$607K 0.01% 290
2024
Q1
Sell
-3,640
Closed -$452K 387
2023
Q4
$452K Buy
+3,640
New +$372K 0.01% 80
2020
Q2
Sell
-348,000
Closed -$23.4M 96
2020
Q1
$23.4M Buy
+348,000
New +$21.7M 0.74% 42
2018
Q3
Sell
-660,700
Closed -$15.7M 106
2018
Q2
$15.7M Sell
660,700
-1,935,300
-75% -$41M 0.55% 68
2018
Q1
$48.1M Sell
2,596,000
-3,540,844
-58% -$52.4M 1.67% 13
2017
Q4
$88M Buy
6,136,844
+457,200
+8% +$5.94M 3.47% 4
2017
Q3
$69.5M Buy
5,679,644
+4,688,280
+473% +$82.9M 3.13% 7
2017
Q2
$18.1M Buy
991,364
+547,396
+123% +$10.1M 0.97% 33
2017
Q1
$9.4M Buy
+443,968
New +$8.67M 0.36% 71

Other funds holding DXCM

Deerfield Management's DXCM Position: Q1 2026 in Review

Deerfield Management sold out of DexCom (DXCM) in Q1 2026, closing a stake of 32,943 shares — an estimated $2.19M sold.

Deerfield Management first reported a position in DXCM in Q1 2017 and held it in 11 quarters. The position peaked at $88M in Q4 2017. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Deerfield Management reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
  • Deerfield Management sold 32,943 DexCom shares in Q1 2026, an estimated $2.19M.
  • Deerfield Management first reported a position in DexCom in Q1 2017 and held it in 11 quarters.
  • Deerfield Management's DexCom position peaked at $88M in Q4 2017.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Deerfield Management's 13F filing for Q1 2026, filed 15 May 2026.